News

After holding last year's meeting in Stockholm, the 3TR consortium returned to Sweden from 9 to 10 October 2024, this time to Gothenburg, for its 5th annual project meeting. Hosted by AstraZeneca, th...

In its latest Annual Report Summary, the Innovative Health Initiative (IHI) featured 3TR’s contribution to better treatments for severe asthma through the development of standard tools for therapy out...

A recent article published by the European Commission’s “Horizon—The EU Research & Innovation Magazine” explores unique perspectives from the 3TR project in understanding immune-system disorders to de...

3TR congratulates Dr Marta Alarcón Riquelme on her recent promotion within the Centre for Genomics and Oncology Research (GENYO), funded by Pfizer, University of Granada-Junta de Andalucía. Since 11 M...

Anna Rattu, research fellow from the Faculty of Medicine at the University of Southampton, has successfully defended her PhD thesis, which was funded by 3TR. In her doctoral research supervised by Pro...

The 3TR partners gathered for the 4th Annual Meeting in Sweden’s capital from 4 – 5 October 2023 upon the invitation of no other than the Karolinska Institutet. To be hosted on their beautiful premise...

Led by the 3TR consortium, a European multi-stakeholder working group has developed 'Core Outcome Measures sets for paediatric and adult Severe Asthma' (COMSA). Core outcome measures (COM) are a set...

Join stakeholders and policymakers at the EU Knowledge Valorisation Week between 25 April and 28 April 2023. The annual event highlights best practices promoting the uptake of research results and sci...

Rheumatoid Arthritis (RA) is one of seven chronic diseases being investigated within the 3TR project. It is a chronic inflammatory disease that affects 0.5-1% of adults in developed countries. Uncontr...

On 20 March 2023, from 2 to 3.30 (UK time), Costantino Pitzalis, Professor of Rheumatology at Queen Mary University of London/Centre for Experimental Medicine and Rheumatology (EMR) and leader of th...

3TR is looking for young persons with asthma or parents of a child/teen with asthma to join the 3TR Advisory Group! The 3TR Advisory Group is organised by the European Lung Foundation (ELF), and t...

After more than two years of virtual annual meetings, the 3TR consortium finally met again in person on 12-13 October in Amsterdam, the Netherlands, kindly hosted by 3TR partner AMC/VUMC. The only pre...

Multiple sclerosis (MS) is one of seven chronic diseases being investigated within the 3TR project. The 3TR MS clinical trial aims to identify biomarkers that predict non-response to MS-specific disea...

The Joint Steering Committee of the 3TR Work Package Leaders has finally met in person again on 5 April 2022. The last in-person meeting has taken place in February 2020, just half a year after the of...

The 3TR Systemic lupus erythematosus (SLE) studies are two of the six prospective clinical studies foreseen within the 3TR project. The SLE studies comprise on the one hand the “flare biomarker study”...

The 3TR Asthma Biologics Cohort (ABC study) is a pan-European prospective translational study aiming to improve personalized medicine for patients with severe asthma. By investigating possible immun...

The drug risankizumab is used to treat adults with psoriasis, but whether it can improve asthma control was unclear. Now, a study released Thursday (28 October 2021) in the New England Journal of Medi...

On 20-21 October, the 3TR consortium gathered once more virtually for its annual meeting. Originally planned as a face-to-face meeting in Amsterdam, the 3TR consortium again had to succumb to the COVI...

3TR brings together a diverse, dedicated team of science enthusiasts and visionary entrepreneurs from different thematic fields and disciplines, who strive to jointly make a difference for patients su...

The 3TR teams for Inflammatory Bowel Disease (IBD) and Engagement with Regulators have joined forces with the Critical Path Institute to host an IBD Biomarker Regulatory Science Webinar on Wednesday ...

With the aim to advance our understanding of the molecular pathways and mechanisms linked to non-response to therapy in inflammatory bowel disease, 3TR has just started an observational open-label stu...

University of Southampton together with the European Lung Foundation just launched a survey on the ELF website for people with asthma or parents or carers of someone with severe asthma. The survey is...

Innovative digital tools empower allergy and respiratory patients to be in control of their healthcare. On 23 and 24 October, the “Allergy and Respiratory Patients’ Digital Conference” focuses on digi...

12 October marks World Arthritis Day. Established by Arthritis and Rheumatism International (ARI) in 1996, this global initiative aims to raise awareness of rheumatic and musculoskeletal diseases (RMD...

On 02-03 October 2020, the 3TR consortium gathered virtually for its first progress meeting. More than 220 participants came together to discuss the progress of the project one year after its kick-off...

Patient Organisations in 3TR Are Raising Awareness for Global Lung Health

Every year on 25 September, World Lung Day aims to raise public awareness about lung health and the global impact of lung di...

The European Respiratory Society (ERS), member of the 3TR consortium, will hold its 30th annual Congress on 7-9 September 2020. Like many other events in times of the COVID-19 pandemic, the Congress w...

On 30-31 October 2019, the 3TR consortium came together in Granada, Spain, to officially kick off the project activities. The meeting was hosted by Marta Alarcón Riquelme, 3TR Coordinator, and her tea...